Carisma Therapeutics Inc. Operating Lease, Expense
Carisma Therapeutics Inc. reported Operating Lease, Expense of $63.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-11-08
- Carisma Therapeutics Inc. operating lease, expense for the quarter ending 2021-09-30 was $63.00K, a 1.56% decline year-over-year.
- Carisma Therapeutics Inc. operating lease, expense for the quarter ending 2021-06-30 was $69.00K, a 6.15% increase year-over-year.
- Carisma Therapeutics Inc. operating lease, expense for the quarter ending 2021-03-31 was $69.00K, a 4.55% increase year-over-year.
- Carisma Therapeutics Inc. operating lease, expense for the quarter ending 2020-09-30 was $64.00K, a 8.47% increase year-over-year.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2021-09-30 | $63.00K 10-Q · filed 2021-11-08 | $132.00K derived: sum of 2 quarters · filed 2021-11-08 | $201.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $69.00K 10-Q · filed 2021-08-09 | $138.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $69.00K 10-Q · filed 2021-05-10 | ||
| 2020-09-30 | $64.00K 10-Q · filed 2021-11-08 | $129.00K derived: sum of 2 quarters · filed 2021-11-08 | $195.00K 10-Q · filed 2021-11-08 |
| 2020-06-30 | $65.00K 10-Q · filed 2021-08-09 | $131.00K 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $66.00K 10-Q · filed 2021-05-10 | ||
| 2019-09-30 | $59.00K 10-Q · filed 2020-11-09 | $112.00K derived: sum of 2 quarters · filed 2020-11-09 | $188.00K 10-Q · filed 2020-11-09 |
| 2019-06-30 | $53.00K 10-Q · filed 2020-08-10 | $129.00K 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $76.00K 10-Q · filed 2020-05-11 |